Transcript all clients

Clients seeking treatment in 2001
for Cannabis
in EU Member States
Linda Montanari, Expert Meeting 23-24 June 2003
All Clients admitted to treatment by main
drug in 2001
0.2
7.0
1.5
5.9
16.3
61.8
7.3
Opiates
Cocaine
Cannabis
Ecstasy
Hallucinogens
Others
Source: 2002 Reitox National Reports; Standard Table 3;
All Centre Types;
N.cases: 283 744 (all clients)
Countries: Dk, Ge, Gr, Sp, Ir, It, Lux, Nl, Fin, Sw, Uk
Amphetamines
New and All clients using cannabis
as primary drug by country
50
45
40
35
30
25
20
15
10
5
0
All
d
la
n
Fi
n
la
nd
s
)
et
he
r
N
Ire
la
nd
(2
(1
)
Fr
a
nc
e
ai
n
Sp
e
ec
G
re
an
y
m
G
er
D
en
m
ar
k
New
Source: 2002 Reitox National Reports; Standard Table 3;
All Centre Types;
N.cases: 109 420 (all clients); 41 356 (new clients)
(1) 1999 data: (2): 2000 data; other countries not present: data not available
New clients admitted to treatment for cannnabis as
main drug in EU from 1996 to 2001
25.0
20.0
15.0
10.0
5.0
0.0
1996
1997
2002 REITOX National Reports
Standard Table 4 – All Centre Types % values
1998
1999
2000
2001
EU Average weighted on the
numbers of new clients by year
Trends of new clients treated for cannabis
by country - 1996 to 200150
45
Denmark
40
Germany
35
Greece
30
Spain
25
France
20
Ireland
15
Netherlands
10
Portugal
5
Finland
0
Sweden
1996
1997
1998
1999
2000
2001
Data not available for: Be, It, Lu, Au, Uk
2002 Reitox National Reports - Standard Table 3 – All Centre Types
Increase in cannabis clients
• 1996 to 2001: + 13%
• 2000-2001: +2.3%
• 2000 – 2001: from 12 964 to 14 435 in
outpatient treatment centres (all clients)
Cannabis Clients
Profile:
Outpatient Treatment Centres
in 2001
TDI data 2001
Mean age of new clients in treatment in 2001 for
cannabis in some countries
New clients asking
treatment for:
Cannabis
(n. 8031)
All Drugs
(n. 31598)
Denmark
25.9
27.7
Germany
19.1
24.0
Greece
20.0
25.1
Spain
23.8
29.0
Ireland
22.8
23.1
Netherlands
26.7
31.2
Finland
21.4
21.8
Sweden
22.6
30.4
Source: 2002 Reitox National Reports - Outaptient Treatment Centres
Year covered: 2001; Be, Ir: 2000 data; other countries not present: data not availble
New clients asking treatment for cannabis by
age group
90
80
Denmark
70
Germany
60
Greece
50
Spain
40
Ireland
30
Netherlands
20
Finland
Sweden
10
0
<15
15 - 19
20 - 29
30 - 39
40 - 49
49+
Source: 2002 Reitox National Reports - Outpatient Treatment Centres
Year covered: 2001 - Ir: 2000 data
Number of cases: new clients 8003 - Valid %
All clients using cannabis by gender
100.0
90.0
80.0
70.0
60.0
50.0
40.0
30.0
20.0
10.0
0.0
Men
Sw
ed
en
nl
an
d
Fi
s
Ne
th
er
la
nd
Ire
la
nd
ai
n
Sp
G
re
ec
e
an
y
G
er
m
De
n
m
ar
k
Women
Source: 2002 Reitox National Reports - Outpatient Treatment Centres
N. Cases: 11 079 - Valid % - Ir: 2000 data; others: 2001 data
Age at first use of main drug among all clients
100%
90%
80%
49+
70%
60%
40-49
50%
30-39
40%
20-29
30%
15-19
20%
<15
10%
0%
Opiates
(n.52142)
Cocaine
(n.16702)
Stimulants
(n.6826)
Cannabis
(n.15381)
Source: 2002 Reitox National Reoprts – Outpatient Treatment Centres
Year covered: 2001 - Valid %
Frequency of use of main drug among all clients
(last 30 days before starting treatment)
80.0
Opiates
(n.24072)
70.0
Cocaine
(n.10476)
Stimulants
(n.11021)
Cannabis
(n.13095)
60.0
50.0
40.0
30.0
20.0
10.0
0.0
Not Used
Once a week 2-6 times a
week
Source: TDI data – Outaptient Treatment Centres
Year covered: 2001 - Valid % on the numbers of users by drug
Daily
Frequency of use of new cannabis clients by country
100%
80%
Daily
60%
2-6
Once
40%
Not used
20%
Sw
ed
en
nl
an
d
Fi
Ne
th
er
la
nd
s
Ire
la
nd
G
re
ec
e
an
y
G
er
m
De
nm
ar
k
0%
Source: 2002 Reitox National Reports - Outaptient Treatment Centres
Year covered: 2001 – Ir: 2000 data
N. cases: 6897 new clients- Valid %
Most used secondary drugs among all clients
10.7
19.4
Cannabis
Cocaine
Opiates
Stimulants
10.8
21.5
Source: 2002 Reitox National Reports - Outaptient Treatment Centres
Year covered: 2001 – Ir: 2000 data
N. cases: 120 490 - Valid %
Most frequent secondary drugs used by
clients using cannabis as primary drug
2.7
10.6
12.5
29.6
Opiates
Cocaine
Amphetamines
MDMA
Hypnotics
Hallucinogens
14.3
0.8
Volatile
Alcohol
6.1
9.0
14.4
Other
Source: 2002 Reitox National Reports - TDI data - Outpatient Treatment Centres – all clients
Year covered: 2001 - Number of cases: 8069 - Ir: 2000 data
Proportion of opiates, cocaine, stimulants
clients using cannabis as secondary drug
Stimulants
37%
Opiates
18%
Cocaine
45%
Source: 2002 National Reports - TDI data - Outpatient Treatment Centres
Year covered: 2001 - Number of cases: Opiates: 57324; Cocaine: 16329; Stimulants: 7417
Conclusions
• The second drug for which clients ask treatment
• Up to 40% among new clients in some countries
• 13% increase in 6 years period
• Similar among countries: profile of clients
• Profile of clients: Men, 22-23 years old
• Age at first use: two groups: 15-19 and <15
• Around 60% using intensively: from 2 to 7 times a week
• Combined often with cocaine, stimulmants (amphetmines and
MDMA), alcohol
Open Questions
• What are the reasons for the increase in
the demand for treatment?
• Why people using cannabis ask for
treatment?
• What are the characteristics of the people
asking treatment for cannabis?
• What are their needs?